Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TONOPORT VI

K-Number: K170966 · 2017-06-14

Decision Date2017-06-14
Product CodeDXN
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

TONOPORT VI is a medical device manufactured by Par Medizintechnik GmbH & Co. KG. It received FDA 510(k) clearance on 2017-06-14 under approval number K170966. The device is classified under product code DXN. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TONOPORT VI?

TONOPORT VI is a medical device that received FDA 510(k) clearance on 2017-06-14. It is manufactured by Par Medizintechnik GmbH & Co. KG. The 510(k) number is K170966.

When was TONOPORT VI approved by the FDA?

TONOPORT VI received FDA 510(k) clearance on 2017-06-14, under approval number K170966.

What company makes TONOPORT VI?

TONOPORT VI is manufactured by Par Medizintechnik GmbH & Co. KG.

What is the FDA product code for TONOPORT VI?

The FDA product code for TONOPORT VI is DXN.

Related Devices (Code: DXN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.